scispace - formally typeset
P

Paula Ray

Researcher at Kaiser Permanente

Publications -  43
Citations -  6226

Paula Ray is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Vaccination & Varicella vaccine. The author has an hindex of 31, co-authored 43 publications receiving 6060 citations. Previous affiliations of Paula Ray include University of Pennsylvania & York University.

Papers
More filters
Journal ArticleDOI

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

TL;DR: The Wyeth Lederle as discussed by the authors determined the efficacy, safety and immunogenicity of the CRM197 pneumococcal conjugate vaccine against invasive disease caused by vaccine serotypes and to determine the effectiveness of this vaccine against clinical episodes of otitis media.
Journal ArticleDOI

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

TL;DR: The heptavalent CRM197 pneumococcal conjugate vaccine was given to infants at 2, 4, 6 and 12 to 15 months of age in a randomized, double blind trial and was effective in reducing the risk of pneumonia in young children.
Journal ArticleDOI

Impact of the pneumococcal conjugate vaccine on otitis media.

TL;DR: In children followed up to 3.5 years, PCV provided a moderate amount of protection against ear infections while reducing frequent otitis media and tube procedures by greater amounts.
Journal ArticleDOI

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

TL;DR: It is concluded that PNCRM7 vaccine was safe and immunogenic and when this vaccine was administered concurrently at the booster dose with DTaP and HbOC vaccines, lower antibody titers were noted for some of the antigens when compared with the antibody response when PNC RM7 was given separately.